XML 144 R57.htm IDEA: XBRL DOCUMENT
v3.19.3.a.u2

Certain Transactions - Other Transactions - Additional Information (Detail) $ in Millions |  |  |  | 1 Months Ended | 3 Months Ended | 12 Months Ended |
--- | --- | --- | --- | --- | --- | --- | ---
Jan. 08, 2018 USD ($) | May 12, 2017 USD ($) | Mar. 03, 2016 USD ($) | Sep. 30, 2018 USD ($) | Dec. 31, 2016 USD ($) | Nov. 30, 2016 USD ($) | Sep. 30, 2016 USD ($) Lawsuit | Dec. 31, 2018 USD ($) | Mar. 31, 2018 USD ($) | Jun. 30, 2017 USD ($) | Sep. 30, 2016 USD ($) | Dec. 31, 2019 USD ($) | Dec. 31, 2018 USD ($) | Dec. 31, 2017 USD ($) | Oct. 31, 2016 USD ($)
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other asset impairments, restructuring and other items |  |  |  |  |  |  |  |  |  |  |  | $ 423.0 | $ 987.0 | $ 1,836.0 |
Net (gain) loss from sale of long-lived assets and investments |  |  |  |  |  |  |  |  |  |  |  | $ (18.0) | $ (19.0) | (1,090.0) |
PGT Healthcare Partnership [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Other asset impairments, restructuring and other items |  |  |  |  |  |  |  |  | $ 64.0 |  |  |  |  |  |
Write-down of investment |  |  |  |  |  |  |  |  | 94.0 |  |  |  |  |  |
Net (gain) loss from sale of long-lived assets and investments |  |  |  | $ 50.0 |  |  |  |  |  |  |  |  |  |  |
Rimsa [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Cash consideration |  |  | $ 2.3 |  |  |  |  |  |  |  |  |  |  |  |
Number of lawsuits filed | Lawsuit |  |  |  |  |  |  | 2 |  |  |  |  |  |  |  |
Alder [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment | $ 25.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Collaborative agreement milestone payments | $ 175.0 |  |  |  |  |  |  |  |  |  |  |  |  |  |
Otsuka [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  | $ 50.0 |  |  |  |  |  |  |  |  |  |  |  |  |
Attenukine [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  | $ 30.0 |  |  |  |  |  |  |  |  |  |
Milestone payment |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 20.0 |
Additional considerations |  |  |  |  | $ 260.0 |  |  |  |  |  |  |  |  |  |
Ninlaro [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  |  | $ 150.0 |  |  |  |  |  |  |  |  |
Payment |  |  |  |  |  | 150.0 |  |  |  |  |  |  |  |  |
Upfornt payments received |  |  |  |  |  | $ 150.0 |  |  |  |  |  |  |  |  |
Celltrion [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Refundable payment |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 60.0
Total associated cost |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ 160.0
Regeneron [Member] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Noncash or Part Noncash Acquisitions [Line Items] |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Upfront payment |  |  |  |  |  |  |  |  |  |  | $ 250.0 |  |  |  |
Collaborative agreement milestone payments |  |  |  |  |  |  |  | $ 60.0 | $ 35.0 | $ 25.0 |  |  |  |  |
Research and development costs |  |  |  |  |  |  | $ 1,000.0 |  |  |  |  |  |  |  |

X
- Definition Additional Considerations + References No definition available. + Details
Name: | teva_AdditionalConsiderations
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Additional Payments + References No definition available. + Details
Name: | teva_AdditionalPayments
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Collaborative Agreement Milestone Payments + References No definition available. + Details
Name: | teva_CollaborativeAgreementMilestonePayments
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Impairments restructuring and others. + References No definition available. + Details
Name: | teva_ImpairmentsRestructuringAndOthers
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Milestone payment. + References No definition available. + Details
Name: | teva_MilestonePayment
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Number Of Lawsuits Filed + References No definition available. + Details
Name: | teva_NumberOfLawsuitsFiled
Namespace Prefix: | teva_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | duration

X
- Definition Profit from sale of long lived assets and investment. + References No definition available. + Details
Name: | teva_ProfitFromSaleOfLongLivedAssetsAndInvestment
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Refundable Payment + References No definition available. + Details
Name: | teva_RefundablePayment
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Research And Development Costs + References No definition available. + Details
Name: | teva_ResearchAndDevelopmentCosts
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Total Associated Cost + References No definition available. + Details
Name: | teva_TotalAssociatedCost
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Upfornt payments received. + References No definition available. + Details
Name: | teva_UpforntPaymentsReceived
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Upfront payments + References No definition available. + Details
Name: | teva_UpfrontPayments
Namespace Prefix: | teva_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Amount of realized and unrealized gain (loss) on investment. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 320 -SubTopic 10 -Section 50 -Paragraph 10 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=118939692&loc=d3e27405-111563 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.7(c),9(a)) -URI http://asc.fasb.org/extlink&oid=116634182&loc=SL114868664-224227 Reference 3: http://www.xbrl.org/2003/role/recommendedDisclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3602-108585 + Details
Name: | us-gaap_GainLossOnInvestments
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_NoncashOrPartNoncashAcquisitionsLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (b)(1) -URI http://asc.fasb.org/extlink&oid=35744584&loc=d3e6927-128479 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=118932676&loc=d3e3213-108585 + Details
Name: | us-gaap_PaymentsToAcquireBusinessesGross
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=teva_PgtMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_RimsaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_AlderMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_OtsukaMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_AttenukineMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_NinlaroMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_CelltrionMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_BusinessAcquisitionAxis=teva_RegeneronMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |